Ananta Khurana (A Khurana)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Venues

Dermatologic therapy

International journal of dermatology

Clinical and experimental dermatology

The Journal of dermatological treatment

Dr Ram Manohar Lohia Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dr Ram Manohar Lohia Hospital

India

Assistant Professor :: Dermatology

Publications

Kabir Sardana, Aishwarya Muddebihal, David M Scollard, Ananta Khurana
Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs. International journal of dermatology (2024)
Siddharth Gogate, Ananta Khurana, Arvind Ahuja, Kabir Sardana
Trans-epidermal extrusion of lepra bacilli from histoid lesions: a risk of continued transmission. International journal of dermatology 63 (4) (2024)
Siddharth Gogate, Ananta Khurana, Arvind Ahuja, Kabir Sardana
Trans-epidermal extrusion of lepra bacilli from histoid lesions: a risk of continued transmission. International journal of dermatology 63 (4) (2024)
Siddharth Gogate, Ananta Khurana, Arvind Ahuja, Kabir Sardana
Trans-epidermal extrusion of lepra bacilli from histoid lesions: a risk of continued transmission. International journal of dermatology (2024)
Aishwarya Muddebihal, Kabir Sardana, Ananta Khurana, Arvind Ahuja, Itu Singh
Time to revisit the purported link of leprosy reactions with infective triggers: An unnecessary economic burden for patients. Tropical doctor (2023)
Anamika Bhattacharyya, Suresh Sadhasivam, Mau Sinha, Swati Gupta, Swamini Saini, Himanshi Singh, Ananta Khurana, Soumya Sachdeva, Kabir Sardana, Shamik Ghosh
Treatment of recalcitrant cases of tinea corporis/cruris caused by T. mentagrophytes - interdigitale complex with mutations in ERG11 ERG 3, ERG4, MDR1 MFS genes & SQLE and their potential implications. International journal of dermatology (2023)
Aishwarya Muddebihal, Ananta Khurana, Kabir Sardana
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review. Expert review of clinical pharmacology (2023)
Soumya Sachdeva, Kabir Sardana, Ritu Kumari, Kavin Bhogar, Ananta Khurana, Purnima Malhotra
Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times. International journal of dermatology 61 (11) (2022)
Savitha Bathula, Kabir Sardana, Sinu Rose Mathachan, Ananta Khurana, Arvind Ahuja, Purnima Paliwal
A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population. International journal of dermatology (2022)
Ananta Khurana, B Savitha
Refractory angiolymphoid hyperplasia with eosinophilia: Complete resolution with low dose thalidomide. Pediatric dermatology 39 (6) (2022)
Snigdha Saxena, Ananta Khurana, Kabir Sardana
Pulsed cyclophosphamide sans pulse steroids in recalcitrant pemphigus: An effective, economical but underutilized modality. Dermatologic therapy 35 (5) (2022)
Sinu Rose Mathachan, Kabir Sardana, Ananta Khurana
A study examining the combination of methotrexate and leflunomide with topical anthralin in pediatric alopecia areata-a possible steroid-free regimen with diverse mechanistic actions. Dermatologic therapy 35 (9) (2022)
Aishwarya Muddebihal, Kabir Sardana, Ananta Khurana, Soumya Sachdeva, Itu Singh, Madhvi Ahuja, Rahul Sharma
A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Ananta Khurana, Aastha Agarwal, Diksha Agrawal, Khushboo Sethia
Re-emerging role of KOH smear examination in the era of recalcirant dermatophytoses. Dermatologic therapy 34 (2) (2021)
Aishwarya Muddebihal, Kabir Sardana, Sinu R Mathachan, Ananta Khurana, Itu Singh, Rahul Sharma
Drug resistance to rifampicin in a case of steroid-dependent erythema nodosum leprosum and the therapeutic implications of resistance and reactions in leprosy. International journal of dermatology 60 (10) (2021)
Ananta Khurana, A Mittal, R Jain, A Mishra, Sinu Rose Mathachan
Rarity of cutaneous findings among asymptomatic to mildly symptomatic patients with COVID-19 admitted to a COVID care facility in Delhi, India: an observational study. The British journal of dermatology 185 (3) (2021)
Kabir Sardana, Sinu Rose Mathachan, S Sachdeva, Ananta Khurana
Is there a rationale for the use of voriconazole in dermatophytosis in the absence of mycological and mutational data? An urgent need for antifungal stewardship. Clinical and experimental dermatology 46 (8) (2021)
Ananta Khurana, Aastha Agarwal, Ashutosh Singh, Kabir Sardana, Manik Ghadlinge, Diksha Agrawal, Sanjeet Panesar, Khushboo Sethia, Anuradha Chowdhary
Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial. Mycoses 64 (12) (2021)
Soumya Sachdeva, Ananta Khurana, Parul Goyal, Kabir Sardana
Does oxidative stress correlate with disease activity and severity in alopecia areata? An analytical study. Journal of cosmetic dermatology (2021)
Ananta Khurana, Sinu Rose Mathachan
Efficacy of bleomycin as a treatment modality in pyogenic granuloma: a case series. Dermatologic therapy 34 (4) (2021)
Sinu Rose Mathachan, Ananta Khurana, Ram Kishan Gautam, Anita Kulhari, Lokesh Sharma, Kabir Sardana
Does oxidative stress correlate with disease activity and severity in vitiligo? An analytical study. Journal of cosmetic dermatology 20 (1) (2020)
Prekshi Bansal, Kabir Sardana, Pooja Arora, Ananta Khurana, Umesh Chandra Garga, Lokesh Sharma
A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne. Dermatologic therapy 33 (6) (2020)
Ananta Khurana, Snigdha Saxena
Immunosuppressive agents for dermatological indications in the ongoing COVID-19 pandemic: Rationalizing use and clinical applicability. Dermatologic therapy 33 (4) (2020)
Ananta Khurana, Anusha Katare, Aastha Agarwal, Priyadharshini Kathirvel, Arvind Ahuja
Hydroxychloroquine-induced erythroderma: A rare adverse effect of a commonly used drug. Dermatologic therapy 33 (6) (2020)
Sweta Singh, Ananta Khurana, Aishwarya Muddebihal, Manish Jangra
Trimetazidine, a hitherto unreported cause of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. Contact dermatitis 84 (3) (2020)
Ananta Khurana, Sinu Rose Mathachan, Ajeet Singh, Arvind Ahuja
Acquired dermal melanocytosis: Causing a rare but characteristic pattern of nasal alar pigmentation. Journal of cosmetic dermatology 19 (12) (2020)
Priyadharshini Kathirvel, Ananta Khurana, Purnima Malhotra, Kabir Sardana
A hypopigmented plaque on the face in a leprosy endemic area and the consequent histological confirmation of follicular mucinosis: an uncommon differential of leprosy in children. International journal of dermatology 59 (12) (2020)
Ananta Khurana, Aastha Gupta, Kabir Sardana, Khushboo Sethia, Sanjeet Panesar, Aastha Aggarwal, Manik Ghadlinge
A prospective study on patterns of topical steroids self-use in dermatophytoses and determinants predictive of cutaneous side effects. Dermatologic therapy 33 (4) (2020)
Kabir Sardana, Sinu Rose Mathachan, Desh Deepak, Ananta Khurana, Surabhi Sinha
Cutaneous side effects of hydroxychloroquine in health care workers in a COVID referral hospital - implications for clinical practice. The Journal of dermatological treatment (2020)
Kabir Sardana, Ananta Khurana, Sanjeet Panesar, Ajeet Singh
An exploratory pilot analysis of the optimal pellet number in 100 mg of itraconazole capsule to maximize the surface area to satisfy the Noyes-Whitney equation. The Journal of dermatological treatment 32 (7) (2020)
Ananta Khurana, Arti Maria, Kabir Sardana, Amlin Shukla, Aastha Gupta
Congenital scars: a rare presentation of neonatal lupus. Archives of disease in childhood. Fetal and neonatal edition 104 (6) (2019)
Kabir Sardana, Ananta Khurana, Ajeet Singh
Scientific rationale of antifungal drug combination, including oral itraconazole and terbinafine, in recalcitrant dermatophytoses. The Journal of dermatological treatment 31 (1) (2019)
Kabir Sardana, Ananta Khurana, Aastha Gupta
Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses. Expert review of clinical pharmacology 12 (5) (2019)
Ananta Khurana, Aastha Gupta, K Sardana, P Malhotra
Late-onset naevus of Ota: a case series of six patients. Clinical and experimental dermatology 44 (6) (2018)
Ananta Khurana, Aradhana Masih, Anuradha Chowdhary, Kabir Sardana, Sagar Borker, Aastha Gupta, R K Gautam, P K Sharma, Dhruv Jain
Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris. Antimicrobial agents and chemotherapy 62 (12) (2018)
Aastha Gupta, Ananta Khurana, A Ahuja, R K Gautam
Description of a new pigmentary demarcation line (Type I). Clinical and experimental dermatology 44 (4) (2018)
Ananta Khurana, K Sardana, V Bhardwaj
Terbinafine induced liver injury may be asymptomatic: need for regular monitoring. The British journal of dermatology 178 (3) (2018)
Anuradha Chowdhary, Ashutosh Singh, Pradeep K Singh, Ananta Khurana, Jacques F Meis
Perspectives on misidentification of Trichophyton interdigitale/Trichophyton mentagrophytes using internal transcribed spacer region sequencing: Urgent need to update the sequence database. Mycoses 62 (1) (2018)
Ananta Khurana, Anuradha Chowdhary, Kabir Sardana, R K Gautam, P K Sharma
Complete cure of Fusarium solani sp. complex onychomycosis with Qs NdYAG treatment. Dermatologic therapy 31 (2) (2017)

Ananta Khurana.css-eqlu8i{font-size:small;padding-left:4px;} (A Khurana)

Publication Activity (10 Years)

Top Topics

Top Venues

Ananta Khurana (A Khurana)